Streetbeat News

Revenues

OVID

TAK

Takeda Pharmaceutical's Phase 3 studies for Soticlestat in treating Dravet syndrome and Lennox-Gastaut syndrome failed. Ovid Therapeutics, which previously sold the rights to Takeda, will update its guidance based on Takeda's next steps. Ovid's shares dropped significantly in premarket trading.

Portfolio Pulse from Vandana Singh

June 17, 2024 | 12:59 pm

BTCUSD

MSTR

El Salvador's President Nayib Bukele has proposed the establishment of a Bitcoin bank to attract significant Bitcoin investments and boost the nation's GDP. The initiative aims to capitalize on Bitcoin's legal tender status in El Salvador and diversify financing options for investors.

Portfolio Pulse from Murtuza Merchant

June 17, 2024 | 12:48 pm

VEV

Vicinity Motor Corp. (NASDAQ:VEV) has received an order for two Vicinity Classic Clean Diesel buses from the Town of Orangeville, Ontario, for delivery in 2025. Financial terms were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:43 pm

EVOK

Evoke Pharma (NASDAQ: EVOK) reports progress in its commercial strategy for GIMOTI, including expanded state Medicaid access and record monthly prescription fills in May 2024. The company also promoted Mark Kowieski to CFO.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:41 pm

STSS

Sharps Technology has shipped its first orders for Securegard disposable smart safety syringes, marking a significant milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:35 pm

NITO

N2OFF has received its first purchase order from a customer in Peru. The terms of the order have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:29 pm

BX

MA

WFC

Wells Fargo's co-branded credit card with Bilt Technologies faces financial challenges, costing the bank up to $10 million monthly. The card, popular among young adults for rent payments, has not met profitability expectations, leading to halted new co-branded card programs and renegotiations with Bilt.

Portfolio Pulse from Vandana Singh

June 17, 2024 | 12:27 pm

ATLX

Atlas Lithium has doubled its lithium exploration footprint in Brazil to approximately 539 km², focusing on the Doce River and Mucuri Valleys. The company is preparing its dense media separation plant for shipment and aims to start production at the Neves Project in Q4 2024. A Definitive Feasibility Study (DFS) is in progress and will be released before production begins.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:14 pm

SATX

SatixFy Communications Ltd. (NYSE: SATX) has secured a significant order worth over $20 million for its Prime2 Space-Grade Digital Beam Former Chips, to be delivered over the next five quarters. This follows a previous $4 million order from September 2023.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:12 pm

ATNM

Actinium Pharmaceuticals presented data at the 2024 EHA Congress showing that its drug Actimab-A, when combined with leading menin inhibitors, enhances cell death in acute myeloid leukemia (AML) cells. The combination therapy demonstrated significant tumor elimination, expanding the potential of Actimab-A in AML treatment.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:11 pm